Astrazeneca (AZN) Goodwill & Intangibles (2009 - 2026)

Astrazeneca's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $58.9 billion for Q2 2026.

• In Q2 2026, Goodwill & Intangibles changed 0.41% year-over-year to $58.9 billion; the TTM figure through Jun 2026 stood at $58.9 billion (changed 0.41% YoY), while the FY2025 annual figure was $59.1 billion, up 1.52% from the prior year.
• Goodwill & Intangibles for Q2 2026 stood at $58.9 billion, up from $58.1 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $93.9 billion in Q4 2023, with the low at $57.6 billion in Q3 2023.
• The 5-year median for Goodwill & Intangibles is $59.1 billion (2022), against an average of $61.1 billion.
• The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles surged 141.32% in 2022, then plunged 37.98% in 2024.
• Astrazeneca's Goodwill & Intangibles stood at $59.1 billion in 2022, then surged by 58.73% to $93.9 billion in 2023, then slumped by 37.98% to $58.2 billion in 2024, then climbed by 1.52% to $59.1 billion in 2025, then dropped by 0.31% to $58.9 billion in 2026.
• Business Quant data shows AZN's Goodwill & Intangibles at $58.9 billion in Q2 2026, $58.1 billion in Q1 2026, and $59.1 billion in Q4 2025.